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We performed a combined approach to identify suspected allergy to knee arthroplasty (TKR): patch test (PT), lymphocyte
transformation test (LTT), histopathology (overall grading; T- and B-lymphocytes, macrophages, and neutrophils), and
semiquantitative Real-time-PCR-based periprosthetic inflammatory mediator analysis (IFN𝛾, TNF𝛼, IL1-𝛽, IL-2, IL-6, IL-8, IL-
10, IL17, and TGF𝛽). We analyzed 25 TKR patients with yet unexplained complications like pain, effusion, and reduced range of
motion. They consisted of 20 patients with proven metal sensitization (11 with PT reactions; 9 with only LTT reactivity). Control
specimens were from 5 complicated TKR patients without metal sensitization, 12 OA patients before arthroplasty, and 8 PT patients
without arthroplasty. Lymphocytic infiltrates were seen and fibrotic (Type IV membrane) tissue response was most frequent in the
metal sensitive patients, for example, in 81% of the PT positive patients.The latter also had marked periprosthetic IFN𝛾 expression.
8/9 patients with revision surgery using Ti-coated/oxinium based implants reported symptom relief. Our findings demonstrate
that combining allergy diagnostics with histopathology and periprosthetic cytokine assessment could allow us to design better
diagnostic strategies.
1. Introduction
Hip and knee replacement are very successful surgical proce-
dures to restore quality of life in osteoarthritis patients [1] and
correspondingly implantation rates are steadily increasing
[2]. However, in a substantial part of such patients implant
failure leads to implant revision. A recent review lists a total
knee replacement (TKR) revision rate of 9.5% in Germany
and of 8.4% in the USA for the year 2011 [2]. Within the
spectrum of conditions leading to TKR failure [3] adverse
reactions may be found, but the role of allergy is still a
controversial issue. Cutaneousmetal allergy is frequent in the
general population, for example, approximately 13% to nickel
(Ni), 2% to cobalt (Co), and 1% to chromium (Cr) [4]. Either
wear or corrosion leads to peri-implant and systemic metal
(particularly Ni, Cr, or Co) exposure of arthroplasty patients
[5], and correspondingly, prevalence of metal sensitivity in
patients with failed implant is reported to be increased [6–8].
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With regard to total hip replacement, aseptic loosening was
mostly attributed to wear associated macrophage dominated
foreign body response as underlying mechanism [9, 10].
Over the last decade, attention has turned to the role of
hypersensitivity in peri-implant inflammation. In particu-
lar in metal-on-metal arthroplasty a subgroup of patients
was described showing rather peri-implant lymphocytic
inflammation as potential elicitor of implant failure [11–13].
Described histologic changes include diffuse, perivascular
or lymph-follicle (lymphoid) like infiltration of lymphocytes
and few macrophages, high endothelial venules, and in
part tissue necrosis [13–15]. Metal allergy as a contributing
factor was suggested by the observed linkage between peri-
implant lymphocytic inflammation, patch test reactivity to
metals, and enhanced lymphocyte transformation test (LTT)
response to metals in a series of such patients [16]. There
is however still controversial discussion, as to which extent
metal allergy contributes to the “umbrella term” adverse
reactions in hip arthroplasty [17, 18]. In fact, metal allergic
patients may well tolerate the respective metals containing
implant [8, 19]. With regard to TKR there also exist reports
on cutaneousmetal allergy found in association with compli-
cations [20, 21], but it is not yet further investigated whether
such metal allergy is responsible for the biological reaction.
As we are seeing patients with suspected implant intolerance
reactions in a special outpatient ambulatory, we wondered
whether in a series of patients with complicated TKR a
potentialmetal sensitivity could be linked to a particular peri-
implant histological picture and cytokine expression pattern.
To address potential clinical relevance of the findings we
further contacted the patients to see if they have had some
benefit from revision surgery with particular attention to
the potential use of “hypoallergenic” materials upon revision
surgery.
Thus, the aim of the investigation was to better prove
allergic etiology in complicated TKR by combining different
diagnostic steps and by assessing the clinical relevance of the
findings in a followup.
2. Materials and Methods
2.1. Patients and Controls. A total of 45 patients took part in
the study. The study was approved by the ethics committee.
The following patient groups were analyzed.
25 knee arthroplasty patients (16m, 9 f, 37–75 years)
with CoCrMo based TKR and complications like loosening,
recurrent effusions, and pain were presented by their treating
orthopaedic surgeons to our ambulatory for allergy diagnos-
tics, since preceding diagnostics gave no indication of prob-
lem elicitors like malpositioning/malalignment, fracture, or
infection. According to the allergy diagnostics results, these
patients were further assigned to three groups. Group I: 11
patients (patch test positive and LTT positive), Group II: 9
patients (patch test negative and LTT positive), and Group
III: 5 patients (patch test negative and LTT negative).
The study included 12 patients (1m, 52–89 years; “OA-
control group”) without implant, but degenerative joint dis-
ease/osteoarthritis (OA) prior to knee arthroplasty.
The study included 8 patients (2m, 53–75 years; “PT-
control group”) without implant, but having undergone patch
test (PT) for suspected allergic skin diseases. 6/8 had Ni-PT
reactivity, 2/8 had no Ni-PT reactivity.
In the 25 TKR patients, potential metal sensitivity was
assessed by PT and LTT; furthermore, periprosthetic tissue
samples were obtained for histology, molecular analysis, and
microbiology. In addition a WOMAC score was obtained
at the ambulatory visit to have feedback on the patients’
perception of daily life activity and of pain. In the 12
OA patients (“OA-control group”), at primary TKR tissue
samples were obtained for histology, molecular analysis, and
microbiology. In the 8 “PT-control group” patients, biopsies
were obtained from the 6 Ni-PT reactive and the 2 Ni-non
reactive PT areas for histology and molecular analysis. The
characteristics of the 45 patients are summarized in Table 1.
2.2. Patch Test (PT). In the 25 TKR patients an European
standard series of 30 contact allergens including a Co, a Cr,
and a Ni preparation (Hermal, Reinbek, Germany) supple-
mented by a metal allergen series (Brial Allergen GmbH,
Greven, Germany) as well as a bone cement component series
in case of cemented arthroplasty was tested on the patients’
back. Test preparations were applied in Finn chambers for 2
days and reactions were evaluated on the day of removal and
at 3 days after application. In the patients with bone cement
series testing, an additional reading was performed after 1
week. Grading of the skin reactions was as recommended by
the German Contact Dermatitis Research Group.
2.3. Lymphocyte Transformation Test (LTT). Peripheral blood
mononuclear cells (PBMC) were obtained from the hep-
arinized blood of the TKR patients by density centrifugation
on Ficoll-Hypaque (Phadia, Freiburg, Germany). Cells (1 ×
10
6
/mL) were cultured in RPMI1640 medium (Biochrom,
Berlin, Germany) supplemented by autologous serum, glu-
tamine, antibiotic-antimycotic-solution, and nonessential
amino acids. All cultures were performed in quadruplicate in
96-well plates (Nunc, Roskilde, Denmark). Stimuli were the
pan T-cell mitogen phytohemagglutinin (PHA) 2.4 𝜇g/mL,







concentrations each from 1×10−4Mto 1×10−6M)and culture
medium alone as control. After 5 days, cells were pulsed with
3H thymidine overnight and proliferation was assessed by
incorporated radioactivity. The stimulation index (SI) was
calculated by the ratio of mean counts per minute (cpm) of
stimulated to unstimulated cultures. SI > 3 was considered as
positive.
2.4. Analysis of Peri-Implant Tissue. In the 25 TKR patients,
tissue specimens were obtained from the newly formed
articular capsule at the time of revision. At least 2 probes
were sent for microbiological evaluation to the Endoklinik
Hamburg.The other two probes were processed for histology
and one probe for molecular analysis. In the 12 OA-patients
tissue specimens were obtained at the moment of primary
arthroplasty implantation for histology and molecular anal-
ysis as above. The 8 “PT-control group” patients underwent
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Table 1: Patients characteristics.
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punch biopsy of their Ni-PT areas on the back after test
reading on D3. One probe each was obtained for histology
and molecular analysis.
2.5. Histological Examination. The formalin-fixed tissues
were processed and stained with haematoxylin-eosin.
Immunohistology was performed with antibodies to T-
cell (𝛼CD3), B-cell (𝛼CD20), macrophage (𝛼CD68 resp
KP1), and neutrophil (𝛼CD15) antigens. The sections were
microscopically examined and the proportionate distribution
of the tissue components including macrophages, diffuse
or perivascular accumulation of T- or B-lymphocytes,
and plasma cells as well as the overall reaction pattern of
the tissue specimen were semiquantitatively assessed. The
grading score was according to Krenn et al. [24] and in
the case of the TKR-patient derived samples the consensus
classification [24] was used. This consensus classification
does subdivide the peri-implant tissue reaction patterns
into a particle dominated foreign body like response (Type
I), a granulocyte dominated infectious type (Type II), the
mixture of Types I and II (combined Type, Type III), and a
paucicellular and rather fibrotic reaction (Type IV, indifferent
type).
2.6. Molecular Analysis. The following probes were obtained
in RNA-conserving liquid for subsequent analysis: from each
of the 25 TKR patients and 12 OA-control patients peri-
implant and subcutaneous tissue (reference) probe; from the
patch test control group 6Ni-PT-positive probes and 2 probes
from Ni-non-reactive test site (reference).
Total RNA was isolated from the tissue specimen by
phenol/chloroform extraction and reverse transcribed into
cDNA by the use of AMV reverse transcriptase. The expres-
sion of the following cytokines was analysed by semiquanti-
tative RT-PCR in the LightCycler: IFN𝛾, TNF𝛼, IL1-𝛽, IL-2,
IL-6, IL-8, IL-10, IL17, and TGF𝛽. The expression value was
determined in comparison to the house-keeping gene EF1-𝛼
[25] by the ΔΔCt-method by Schmittgen and Livak [22].
2.7. Comparison of Pre- and Postoperative WOMAC Score. A
modified score system has been used in accordance with the
publication of Roos et al. [23]. As from the Groups I and II
patients preoperative WOMAC knee score was available, we
further contacted patients after revision surgery to also get
(at not less than 6 months after surgery) their postoperative
WOMAC score information. Particular focus was put on
patients with revision by use of “hypoallergenic” material.
3. Results and Discussion
Metal implant allergy still remains a diagnosis of exclusion,
with a delay in diagnosis due to missing disease specific
criteria and need of combining different diagnostic steps.
Thus various complication elicitors are questioned first in
TKR failure and metal implant allergy is diagnosed by
a combination of PT, LTT, and histopathology [26, 27].
The study presented here aims to support improvement of
diagnostic tools.
3.1. Allergy Diagnostics. Within the 20 patients with metal
sensitivity, 11 (Group I) showed PT reactions to metals (in
part multiple reactions): 10 to Ni, 6 to Co, 2 to Cr, and
one of these 11 patients also showed PT reactions to bone
cement components (to gentamicin and benzoyl peroxide).
In 6/11 additional LTT data were available and showed 5x
Ni reactivity and 1 nonreactive LTT. In the remaining 9
patients (Group II) with negative PT to implant components
but positive LTT we found 9x LTT reactivity to Ni, 1x to
Co. These data are summarized in Tables 2–4. In several
studies increased metal sensitivity has been found in patients
with arthroplasty [6, 7]. At a larger scale, when comparing
100 symptom-free to 200 complicated arthroplasty patients,
such increased incidence of metal allergy—in particular to
Ni—could be reproduced [21]. Most data on in vivo metal
release conditions are derived from hip arthroplasty patients.
However local Co and Cr release is seen also in TKR and
respective systemic exposure of the patients is reported [28].
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CD3-infiltrate KP1 CD20 CD15 Rating (Type I–IV
according to [24])Qualitative Quantitative
10 37, m Ni, Co, Cr n.d. Micronodalperivascular + ++ − − Type 4
8 51, f Ni, Ni, Micronodalperivascular ++ + − − Type 4
15 59, f Ni n.d. Micronodalperivascular ++ ++ + − Type 4
9 74, m Ni, Co n.d. Micronodalperivascular +++ ++ − − Type 4
3 51, m Co n.d. Diffuse − + − − Type 4
18 58, f Ni, Ni Diffuse − − − − Type 1 (Necrosis)
7 75, m Ni Ni Diffuse + ++ − − Type 4
1 63, m Ni, Co, Ge,Be Ni Diffuse + ++ + + Type 4
16 57, m Ni, Co Ni Diffuse + + − − Type 4
17 68, m Ni, Co, Cr, n.d. Diffuse + + − − Type 4
19 56, f Ni, neg Diffuse + ++ − − Type 1
Findings in 11 patients with CoCrMo based knee arthroplasty with complications and positive patch test reaction. Ni = nickel, Co = cobalt, Cr = chromium,
Ge = gentamicin, B = benzoyl peroxide; n.d. = not done; LTT = lymphocyte transformation test.





CD3-infiltrate KP1 CD20 CD15 Rating (Type I–IV
according to [24])Qualitative Quantitative
11 61, m neg Ni Diffuse − + − − Type 4
12 65, f neg Ni Diffuse − ++ − − Type 1
14 66, m neg Ni, Co Diffuse − ++ − − Type 4
2 71, m neg Ni Diffuse + ++ + − Type 1
4 66, m neg Ni Diffuse + + − − Type 4
5 64, m neg Ni Diffuse + + − − Type 4
6 53 m neg Ni Diffuse + ++ − − Type 4
13 69, m neg Ni Diffuse + − − − Type 4
20 63, f neg Ni Diffuse + ++ − + Type 1
Findings in 9 patients with CoCrMo based knee arthroplasty with complications, negative patch test but positive lymphocyte transformation test (LTT);
abbreviations see Table 2.





CD3-infiltrate KP1 CD20 CD15 Rating (Type I–IV
according to [24])Qualitative Quantitative
IAR 6 59, f neg Neg − − − − − n.a.∗
IAR 18 73, f neg Neg − − − − − Type 4
IAR 23 74, f neg Neg − − − − − Type 4
IAR 26 68, m neg Neg − − − − + Type 2
IAR 5 75, m neg Neg Focal +++ +++ +++ +++ Type 2
∗n.a.: not applicable because of fibrinoid necrosis.
Findings in 5 patients with CoCrMo based knee arthroplasty with complications, negative patch test, and negative LTT; for abbreviations see Table 2.
Furthermore, also substantial Ni release might be observed
in CoCrMo-arthroplasty patients [29]. The predominance of
Ni allergy in our patient groups might thus not only reflect
relative predominance ofNi allergy in the general population.
On the other hand, even symptom-free patients with well
performing knee arthroplasty may have cutaneous metal
allergy to implant alloy metals [8, 19]. Thus, as Granchi et
al. stated in 2012 [30] that presence of metal sensitivity may
not mean implant failure mechanism at the single patient
level.
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Figure 1: (a) Example of perivascular lymphocytic infiltrate; 𝛼CD3
stain. (b) Example of scattered periprosthetic lymphocytes; 𝛼CD3
stain.
3.2. Histological Examination. We next wondered if the
periprosthetic tissue analysis would help to discriminate
hyperergic tissue response. For this purpose, four conditions
were chosen for comparative analysis of tissue specimen.
For example, periprosthetic tissue samples were obtained
from (1) the 20 TKR patients with complications and metal
sensitivity (Groups I and II); (2) the 5 TKR patients with
complications but no metal sensitivity (Group III); (3) 12
patients with degenerative knee joint disease/osteoarthritis
(OA-control group) at primary arthroplasty; and (4) the
cutaneous biopsies that were performed at PT sites in 8
PT patients (PT-control group) of whom 6 had positive,
eczematous PT reaction to Ni and 2 had no PT reaction to Ni.
The rating of periprosthetic/(neo) capsule tissue responsewas
done according to the standardized consensus classification
initially published by Morawietz et al. in 2006 [31] and
revised by Krenn et al. [24]. In addition focus was put on
the presence of T-lymphocytes, B-lymphocytes, neutrophils,
and macrophages—and furthermore probes of Groups I, II,
and III patients were also sent to microbiology evaluation.
Several unexpected findings were made: 9/11 patients in
Group I and 6/9 patients in Group II had a collagen fibre rich,
connective tissue resembling periprosthetic tissue reaction
(Type IV/indeterminate type). And only 5 of the 20 metal
sensitive patients had the overall picture of the “wear particle
induced type” with macrophage dominated response. This
is in contrast to the general observation of mostly wear
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Figure 2: (a) Histology of patch test (PT) reaction to Ni showing
perivascular T-lymphocytic infiltrates, scattered eosinophils, and
epidermal “spongiotic” changes. (b) Relative inflammatorymediator
expression in biopsy of positive PT reaction to Ni. Analysis based on
semiquantitative real-time RT-PCR.
arthroplasty and to the only 15% Type IV (fibrotic) response
reactivity in the 370 samples analysed by Morawietz et al.
[31]. There were no signs of infections in these 20 samples
of our Groups I and II patients. Despite being a predominant
“arthrofibrosis”-like, paucicellular reactivity, presence of lym-
phocytes was noted in perivascular or scattered distribution
(Figures 1(a) and 1(b)). In contrast, out of the 5 patients
without metal sensitivity two showed infection and lympho-
cytic inflammation was only seen in one of these patients. In
OA-patients, again, lymphohistiocytic infiltrates were noted
together with absence of neutrophils. These findings are
summarized in Tables 2, 3, and 4. Figures 1(a) and 1(b) are
representative histology findings of patients in Groups I and
II. Biopsies from Ni-induced allergic patch test reactions
were characterized by perivascular and sometimes diffuse
lymphohistiocytic infiltrates together with contact allergy-
typical epidermal changes as shown in a representative sam-
ple (Figure 2(a)).Witzleb et al. speculated that perivascular or
diffuse presence of (T-)lymphocytes in periprosthetic tissue
could be interpreted as hyperergic response [15]. However,
von Domarus and coworkers [32] described T lymphocyte
infiltration as a commonfinding in tissue samples of retrieved
aseptically loosened metal-on-polyethylene arthroplasties.
Thus, they conclude that neither necrobiosis nor infiltration
of T-lymphocytes should be considered to be specific for
metal hypersensitivity reaction.



































































































































Figure 3: (a) Cytokine expression of IFN𝛾 in the tissues of the 5 different patient groups; cytokine expression was analysed in comparison
to the house-keeping gene EF-1𝛼 and to the patients control tissue by the ΔΔCt-method [22]; ∗∗ = 𝑃 < 0.005 (Wilcoxon-Mann-Whitney-
test done by SPSS statistical software). (b) Cytokine expression of IL-2 in the tissues of the 5 different patient groups; cytokine expression
was analysed in comparison to the house-keeping gene EF-1𝛼 and to the patients control tissue by the ΔΔCt-method [22]; ∗∗ = 𝑃 < 0.005
(Wilcoxon-Mann-Whitney-test done by SPSS statistical software). (c) Cytokine expression of TGF𝛽 in the tissues of the 5 different patient
groups; cytokine expression was analysed in comparison to the house-keeping gene EF-1𝛼 and to the patients control tissue by the ΔΔCt-
method [22] (Wilcoxon-Mann-Whitney-test done by SPSS statistical software).
3.3. Cytokine Expression Profile. In view of the partly
inconclusive publications [27, 32–34] we next wondered
whether assessment of inflammatory mediator expression
could improve characterization of the tissue response pattern.
In Figure 2(b) the cytokine RNA expression pattern of an
acute ongoing specific cutaneous delayed type hypersen-
sitivity reaction to Ni is shown. Major findings are the
marked upregulation of IFN𝛾 as typical marker of the Th1-
response stimulating the cellular immune response and of IL-
2 indicating T-cell activation and proliferation [35]. When
assessing the groups of metal TKR patients with/without
metal sensitivity and OA-control group, such upregulation
of IFN𝛾 was also particularly visible in Group I patients, for
example, TKR with complications and patch test reactivity
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to metals. Out of the other mediators assessed, in the TKR
patients IL-2 expression was more prominent in Group I and
in OA-patient Group - and TGF-ß expression slightly more
in Groups I and II. This is the case also for IL-6 (in Groups I
and II) and one patient in Group II (patient with peripros-
thetic infection). These other mediators are not shown as
there was only some individual increase of TNF𝛼 in OA-
patients but nomajor difference between the different groups.
Increased TH1 lineage commitment is reflected by increased
IFN𝛾 expression. Here we found marked IFN𝛾 upregulation
not only typically in the Ni-induced PT reactions, but in
particular also in theGroup I TKRpatients, suggesting its role
in periprosthetic disease progression. Interestingly, Jämsen
and coworkers recently reported that they found scattered
CD3+ T cells in the interface tissue of aseptically loosened
hip arthroplasty with predominant macrophage related wear
particle response. However, neither by quantitative PCR nor
by immunohistochemistry they could show significant TH1
(namely, IFN𝛾) orTH2 (IL-4)mediator expression [36]. Since
apart from IL-6 [37] in particular TGF-ß might play a central
role in the onset and persistence of periprosthetic, articular
fibrosis [38], we here analysed its respective expression in the
different tissue samples. We observed an increase of TGF-ß
expression in the metal sensitive TKR patients with however
interindividual variations. Figures 3(a)–3(c) summarize these
findings.
3.4. Comparison of Pre- and Postoperative WOMAC Score.
19 of the 20 TKR patients responded to our request and
completed a postoperative WOMAC scoring. 9 patients
reported that at revision a “hypoallergenic” TKR had been
implanted (8x Ti-based surface coating, 1x oxinium based
implant). 8/9 patients did profit from this approach, as shown
in Figure 4. So far there are only case reports or small
patient series regarding the potential benefit from the use of
“hypoallergenic” TKR [39, 40]. These results however stress
the need of follow-up studies at a larger scale.
There are however limitations in the study: the facts that
periprosthetic tissue samples may reflect only the actual stage
of a dynamic process and that OA patients may not be as well
a “control” as interface tissue probes from patients with well-
functioning implants and the limited sample number in this
investigations.Thus further studies are needed to validate the
multimodular diagnostic approach in metal implant allergy.
4. Conclusions
This study demonstrates for the first time the potential of
utilizing combined analytic steps to provide an approach to
develop diagnostic characteristics of metal implant allergy.
Allergy diagnostics (PT and LTT) and periprosthetic histol-
ogy point to immunological response to implant alloy metals
and the pattern of inflammatory mediator expression adds to
functional differentiation.
Unexpected findings were the predominant “fibrotic”
type IV interface response in the metal sensitized TKR





















Figure 4: WOMAC score before and after revision surgery in 9
patients who received “hypoallergenic” material (8x titanium, 1x
oxinium). The score-system has been used in accordance with the
publication of Roos et al. [23].
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